Factor | RR | CI | p |
---|---|---|---|
Univariate Cox regression: | Â | Â | Â |
 Age: ≤65 versus >65 (years) | 1.004 | 0.224–4.495 | 0.995 |
 ECOG performance status: 0 versus >1 | 0.898 | 0.105–7.692 | 0.922 |
 Lymphnode involvement: N0 versus N1 | 0.476 | 0.057–3.956 | 0.492 |
 Gleason score: ≤7 versus ≥8 | 2.224 | 0.496–9.976 | 0.297 |
 Surgical margins: R0 versus R1 | 0.558 | 0.125–2.496 | 0.445 |
 Androgen deprivation therapy: no or yes | 0.91 | 0.175–4.741 | 0.911 |
 Pelvic nodal RT: no or yes | 0.635 | 0.076–5.288 | 0.674 |
 Presurgery PSA: ≤10 versus >10 (ng/ml) | 6.537 | 0.785–54.411 | 0.082 |
 PSA Persistance after surgery: <0.5 versus ≥0.5 (ng/ml) | 4.623 | 1.029–20.781 | 0.046 |
 PSA at start of RT <0.5 versus ≥0.5 (ng/ml) | 2.980 | 0.659–13.473 | 0.156 |
Multivariate Cox regression: | Â | Â | Â |
 Presurgery PSA: ≤10 versus >10 (ng/ml) | 4.402 | 0.474–40.891 | 0.192 |
 PSA Persistance after surgery: <0.5 versus ≥0.5 (ng/ml) | 2.724 | 0.556–13.337 | 0.216 |